Changes
Jump to navigation
Jump to search
Venture Backed Companies in Fortune 500 (view source)
Revision as of 14:31, 22 April 2016
, 14:31, 22 April 2016→Medical, Health, and Life Sciences
===Medical, Health, and Life Sciences===
MHLS companies have generally performed well, but experience less rapid growth than Information Technology firms. Within the MHLS, there is a tale of two subclasses: MHLS subclass (traditional healthcare providers/hospitals) and Biotech firms. *MHLS Industry firms waited an average of 22 years before reaching the Fortune 500. Compared to the IT figure of 14 years, or the Non-High tech figure of 29. *Since 2007, Biotech firms have experienced more rapid and sustained growth than their traditional counterparts within the MHLS sector. Currently, 80% of all VC backed biotech firms that have reached the fortune 500 remain, compared to around 50% of MHLS subclass. *Traditional health providers post consistently stable growth rates, and rarely surprise. Just over half of traditional MHLS firms stay in the F500 for more than 15 years. *Biotech firms wait for a while to enter the Fortune 500. On average, these companies wait 25 years before reaching the F500. Compared to MHLS subclass companies, a Biotech business waits five extra years before reaching the F500.
===Non-High Technology===